Moreover, we found that the expression level of TFRC in AML patient-derived leukemia cells did not show a significant difference from AML cells with the different expression levels of GPR56 or CD34 (GSE129094, Additional file 1: Fig. S5a). This evidence concerns the gene CD34 and leukemia.